Multiomic profiling of cardiometabolic diseases (Illumina)

The National Institutes of Health (NIH) is seeking a vendor to provide methylation and genotyping arrays produced and manufactured by Illumina. The arrays will be used by the Center for Research on Genomics and Global Health to study gene methylation, genetic variations, and methylation quantitative traits in previously recruited participants. The vendor shall provide Infinium Methylation EPIC v2 kits and Infinium Global Diversity Array -8 v1.0 Kit. The period of performance is expected to be within 1 year. Key requirements include: • Providing Infinium Methylation EPIC v2 kits (96-sample kits) • Providing Infinium Global Diversity Array -8 v1.0 Kit (96 samples) • Ensuring the arrays are compatible with the NHGRI Genomics Core's equipment and expertise